article thumbnail

STAT+: FTC report finds PBMs profit at the expense of patients and independent pharmacies

STAT

Moreover, the FTC found the prescription drug market is “highly concentrated” because the largest PBMs are owned by insurers and, in turn, own specialty, mail order, or retail pharmacies. Continue to STAT+ to read the full story…

article thumbnail

STAT+: Pharmacies sue GoodRx and PBMs over ‘illegal’ reimbursement fees

STAT

Three independent pharmacies have filed separate lawsuits accusing GoodRx, which markets a prescription drug discount card, of conspiring with several pharmacy benefit managers to fix reimbursement fees, the latest skirmish over the opaque pharmaceutical supply chain in the U.S. and, consequently, represent a lucrative market.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Wall Street wags say a bill to force insurers or PBMs to sell pharmacies has low odds

STAT

The bipartisan bill , which would require divestiture within three years, is aimed at what the lawmakers call an “inherent conflict of interest” that has forced Americans to pay more for medicines and hastened the demise of independent pharmacies.

article thumbnail

'We're scaling up hub and spoke in our independent pharmacy group'

The Pharmacist

Brothers Chris and Jonathan Lo, of Lo's Pharmacy Group, speak about why they chose a hub and spoke approach and the impact it has had on their business Lo’s Pharmacy Group, based in South Yorkshire, introduced a hub and spoke model of dispensing for their original pack repeat prescriptions over a year ago.

article thumbnail

STAT+: Pharmalittle: We’re reading about a FTC PBM report, a Kroger deal on opioids, and more news

STAT

Last year, the agency released its first interim staff report that found dominant, vertically integrated PBMs use their outsized market share to profit off of patients and independent pharmacists.

article thumbnail

STAT+: Express Scripts sues FTC over a ‘biased’ report about pharmacy benefit managers

STAT

” The lawsuit also alleged the FTC “followed prejudice and politics, not evidence or sound economics, and wrongly concluded that PBMs inflate drug costs and harm independent pharmacies.” ” FTC Chair Lina Khan was also accused of “anti-PBM bias.”

article thumbnail

Budget changes could cost each pharmacy ‘£12k more a year’

The Pharmacist

Increases to Employers’ National Insurance Contributions (NIC) and National Living Wage (NLW) outlined in the Autumn Budget could cost an average community pharmacy premises more than £12,000 each year - totalling around £125m across the sector as a whole.